<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.3389/fmicb.2019.00814</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Identification of a New HCV Subtype 6xg Among Injection Drug Users in Kachin, Myanmar</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Mei</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/718351/overview"/></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Xin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/718420/overview"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yu</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Duo</surname><given-names>Lin</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/718419/overview"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Chiyu</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/664621/overview"/></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Yong-Tang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/420766/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences, The National Kunming High Level Biosafety Research Center for Nonhuman Primate, KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences</institution>, <addr-line>Kunming</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>Kunming College of Life Science, University of Chinese Academy of Sciences</institution>, <addr-line>Kunming</addr-line>, <country>China</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Pathogenic Biology, School of Basic Medical Sciences, Gannan Medical University</institution>, <addr-line>Ganzhou</addr-line>, <country>China</country></aff><aff id="aff4"><sup>4</sup><institution>KIZ-SU Joint Laboratory of Animal Model and Drug Development, College of Pharmaceutical Sciences, Soochow University</institution>, <addr-line>Suzhou</addr-line>, <country>China</country></aff><aff id="aff5"><sup>5</sup><institution>Yunnan Fuwai Cardiovascular Hospital</institution>, <addr-line>Kunming</addr-line>, <country>China</country></aff><aff id="aff6"><sup>6</sup><institution>Pathogen Discovery and Big Data Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Shiu-Wan Chan, The University of Manchester, United Kingdom</p></fn><fn fn-type="edited-by"><p>Reviewed by: Dahlene N. Fusco, Tulane University, United States; Chao Qiu, Fudan University, China</p></fn><corresp id="c001">*Correspondence: Chiyu Zhang, <email>zhangcy1999@ips.ac.cn</email> Yong-Tang Zheng, <email>zhengyt@mail.kiz.ac.cn</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Virology, a section of the journal Frontiers in Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>18</day><month>4</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>10</volume><elocation-id>814</elocation-id><history><date date-type="received"><day>03</day><month>12</month><year>2018</year></date><date date-type="accepted"><day>01</day><month>4</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Ye, Chen, Wang, Duo, Zhang and Zheng.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Ye, Chen, Wang, Duo, Zhang and Zheng</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Characterizing hepatitis C virus (HCV) genetic diversity not only allows us to trace its origin and evolutionary history, but also provides valuable insights into diagnosis, prevention and therapy of HCV infection. Although eight HCV genotypes and 86 subtypes have been classified, there are still some HCV variants that need to be assigned. The genotype 6 is the most diverse HCV genotype and mainly prevalent in Southeast Asia. In this study, we identified a new HCV subtype 6xg from injection drug users (IDUs) in Kachin, Myanmar. A distinctive feature of 6xg from other subtypes of the genotype 6 was a Lys insertion in NS5A gene, which changes the RRKR/K motif into RRKKR/K. Bayesian analyses showed that HCV 6xg originated during 1984&#x02013;1988, and experienced a rapid population expansion during 2005&#x02013;2009. We characterized HCV subtype profile among IDUs in this region, and detected six HCV subtypes, including 1a (12.0%), 3a (12.0%), 3b (24.0%), 6n (16.0%), 6xa (20.0%), and 6xg (12.0%). Importantly, we found that HCV subtype distribution in Kachin was very similar to that in Dehong prefecture of Yunnan, but very distinct from those in other regions of Myanmar and Yunnan, indicating that the China&#x02013;Myanmar border region shared a unique HCV subtype pattern. The appearance of 6xg and the unique HCV subtype profile among IDUs in the China&#x02013;Myanmar border region have significant epidemiological and public health implications.</p></abstract><kwd-group><kwd>hepatitis C virus</kwd><kwd>injection drug users</kwd><kwd>subtype</kwd><kwd>HCV 6xg</kwd><kwd>Myanmar</kwd><kwd>Yunnan</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></funding-source><award-id rid="cn001">U1302224, 81601802, 81271892</award-id></award-group></funding-group><counts><fig-count count="6"/><table-count count="2"/><equation-count count="0"/><ref-count count="53"/><page-count count="12"/><word-count count="0"/></counts></article-meta></front><body><sec><title>Introduction</title><p>Despite living in the era of high-efficiency antiviral treatments (Sofosbuvir/Velpatasvir/Voxilaprevir: Vosevi) (<xref rid="B11" ref-type="bibr">Heo and Deeks, 2018</xref>), hepatitis C virus (HCV) infection is still a major global health problem especially for the developing world (<xref rid="B23" ref-type="bibr">Luhmann et al., 2015</xref>; <xref rid="B12" ref-type="bibr">Hlaing et al., 2017</xref>; <xref rid="B42" ref-type="bibr">WHO, 2017</xref>). There are about 71 million people living with chronic HCV infection including about 1.75 million new HCV infections worldwide and about 399,000 deaths from HCV-related cirrhosis and hepatocellular carcinoma per year (<xref rid="B42" ref-type="bibr">WHO, 2017</xref>).</p><p>Hepatitis C virus is a blood-borne RNA virus that is primarily transmitted through risk factors of injection drug use (IDU), blood transfusion, and sexual contact (<xref rid="B7" ref-type="bibr">Degenhardt et al., 2017</xref>). IDUs are the most high-risk population for HCV infection and have very high HCV prevalence (<xref rid="B7" ref-type="bibr">Degenhardt et al., 2017</xref>). As the most main drug-producing and drug-trafficking area during the second half of the last century, the&#x0201c;Golden triangle&#x0201d; and surrounding Southeast Asian countries/regions were worst affected by drugs and some IDU-associated infectious diseases, such as HCV and HIV-1 (<xref rid="B50" ref-type="bibr">Zhang et al., 2002</xref>; <xref rid="B52" ref-type="bibr">Zhou et al., 2011</xref>, <xref rid="B53" ref-type="bibr">2012</xref>). Around 26% of the global HCV infections among IDUs was estimated to occur in Southeast Asia (<xref rid="B7" ref-type="bibr">Degenhardt et al., 2017</xref>). The China&#x02013;Myanmar border region is one of the regions with high HCV prevalence among IDUs (<xref rid="B52" ref-type="bibr">Zhou et al., 2011</xref>, <xref rid="B53" ref-type="bibr">2012</xref>; <xref rid="B19" ref-type="bibr">Li et al., 2014</xref>). Our previous studies showed that HCV prevalence among IDUs along the China&#x02013;Myanmar border was over 69% on the Yunnan side, and 48.1% on the Myanmar side (<xref rid="B52" ref-type="bibr">Zhou et al., 2011</xref>, <xref rid="B53" ref-type="bibr">2012</xref>). A study conducted in 2007 reported a much higher HCV prevalence (66.3&#x02013;93.5%) among IDUs in Myanmar (<xref rid="B36" ref-type="bibr">Thu et al., 2008</xref>). Furthermore, a national survey carried out in 2015 revealed that HCV prevalence among the general population was 2.7% in Myanmar, which was much higher than the global prevalence rates of 1% (<xref rid="B24" ref-type="bibr">Lwin et al., 2017</xref>; <xref rid="B28" ref-type="bibr">Ministry of Health and Sports Myanmar, 2017</xref>; <xref rid="B42" ref-type="bibr">WHO, 2017</xref>). These indicated a very severe HCV epidemic among IDUs in Myanmar and the China&#x02013;Myanmar border region.</p><p>Hepatitis C virus belongs to the <italic>Hepacivirus</italic> genus of the <italic>Flaviviridae</italic> family and has a high genetic diversity (<xref rid="B40" ref-type="bibr">Webster et al., 2015</xref>). Currently, HCV is classified into seven genotypes, six of which are further divided into some subtypes (<xref rid="B32" ref-type="bibr">Smith et al., 2014</xref>). As of June 2017, a total of 86 HCV subtypes had been confirmed by the International Committee on Taxonomy of Viruses<sup><xref ref-type="fn" rid="fn01">1</xref></sup>. The genetic distances between HCV genotypes are approximately 30&#x02013;35% in genome level, and the distances between subtypes are 15&#x02013;20% (<xref rid="B32" ref-type="bibr">Smith et al., 2014</xref>). There were some HCV variants that meet the threshold, but need to be assigned as new subtypes (<xref rid="B22" ref-type="bibr">Lu et al., 2006</xref>, <xref rid="B21" ref-type="bibr">2013</xref>; <xref rid="B15" ref-type="bibr">Hubschen et al., 2011</xref>; <xref rid="B38" ref-type="bibr">Wang et al., 2013</xref>; <xref rid="B18" ref-type="bibr">Li et al., 2015</xref>; <xref rid="B37" ref-type="bibr">Wan et al., 2016</xref>). Recently, the eighth HCV genotype was identified from four patients in India (<xref rid="B2" ref-type="bibr">Borgia et al., 2018</xref>). In our previous study, we characterized HCV diversity among IDUs in Dehong prefecture of Yunnan, bordering with Myanmar, and found four special HCV variants from the Burmese IDUs who lived or stayed in Yunnan (Burmese IDUs staying in Yunnan), which formed an independent clade and diverged from the subtype 6n in the C/E2 and NS5B genomic regions (<xref rid="B37" ref-type="bibr">Wan et al., 2016</xref>). The finding suggested that these variants belong to a potential new HCV subtype. However, because of the lack of the full-length genomic sequences, we were unable to define them as a new HCV subtype. Furthermore, Burmese IDUs staying in Yunnan appeared to be relatively separated from the local IDUs in IDU behavior (<xref rid="B37" ref-type="bibr">Wan et al., 2016</xref>), suggesting that they acquired infection with the new variants in Myanmar. To further identify these variants and trace their origin, we performed a HCV molecular epidemiological investigation among IDUs in Kachin, Myanmar, which borders with Dehong prefecture of Yunnan (<xref ref-type="fig" rid="F1">Figure 1</xref>), and identified these variants as a new HCV subtype 6xg by full-length genomic sequence analyses.</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Geographical location and HCV subtype distribution among IDUs in Kachin, Myanmar. The data on HCV subtype profiles in Dehong, Kunming, Honghe and Wenshan, and Yangon were retrieved from previous studies (<xref rid="B31" ref-type="bibr">Shinji et al., 2004</xref>; <xref rid="B51" ref-type="bibr">Zhang et al., 2013</xref>; <xref rid="B3" ref-type="bibr">Chen et al., 2015</xref>; <xref rid="B37" ref-type="bibr">Wan et al., 2016</xref>).</p></caption><graphic xlink:href="fmicb-10-00814-g001"/></fig></sec><sec sec-type="materials|methods" id="s1"><title>Materials and Methods</title><sec><title>Ethics Approval and Study Design</title><p>The study was approved by the Ethics Committee of Kunming Institute of Zoology, Chinese Academy of Sciences (approval number: SWYX-2013023; date: September 6, 2013). Written informed consents were obtained from each participant prior to the study.</p><p>With the support of HIV/AIDS Asia Regional Program Yunnan Management Office, a cross-sectional survey was carried out in detoxification centers in the Mai Ja Yang region of Kachin State, Myanmar, 2014 (<xref ref-type="fig" rid="F1">Figure 1</xref>). Socio-demographic information including gender, age, occupation, education level, ethnicity, marital status, cross-border behavior and duration of drug abuse was collected by trained interviewers with a standard questionnaire. About 5 milliliters of whole blood samples were collected from each participant using vacuous ethylenediaminetetraacetic acid dipotassium salt (EDTA-2K) tubes. Plasma was separated by centrifugation and then stored at -80&#x000b0;C freezer until use.</p></sec><sec><title>HCV Testing</title><p>The HCV serostatus was determined with enzyme-linked immunosorbent assay testing kit for IgG antibodies against HCV (Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Beijing, China), according to the manufacturer&#x02019;s instructions.</p></sec><sec><title>PCR Amplifications</title><p>Viral RNA was extracted from 200 &#x003bc;l of plasma using the High Pure Viral RNA Kit (Roche Diagnostics Ltd., Mannheim, 11858882001). Reverse transcription was performed using PrimeScript II 1st Strand cDNA Synthesis Kit (TaKaRa Biomedical Technology Co., Ltd., Beijing, 6210A). The cDNA was amplified with a nested-PCR using TransTaq DNA Polymerase High Fidelity kit (Beijing TransGen Biotech Co., Ltd., AP131-13). Partial HCV fragments in C/E2 (H77: 849-2152) and NS5B (H77: 8266&#x02013;9303) regions were amplified using the primers described previously (<xref rid="B37" ref-type="bibr">Wan et al., 2016</xref>). In order to obtain the near full-length genome of HCV (H77: 18-9371), we initially attempted to amplify the full-length genome (&#x0003e;5000 bp) using long-range RT-nested PCR with various primer sets, but failed in all these amplifications. Therefore, 10 overlapping HCV genomic fragments were amplified using RT-nested PCR. The information of all primers used in this study is shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>. The PCR products were purified using a Gel Extraction Kit (Bioteke Corporation, DP1503) in accordance with the manufacturer&#x02019;s protocol, and subjected to Sanger sequencing with an ABI PRISM 377XL DNA sequencer (Applied Biosystems, Carlsbad, CA, United States).</p></sec><sec><title>Phylogenetic Analyses</title><p>The obtained sequences were aligned with HCV subtype reference sequences using HCVAlign<sup><xref ref-type="fn" rid="fn02">2</xref></sup> and then were manually edited using Bioedit v7.0. The best substitution model for phylogenetic analyses was inferred using Jmodeltest v2.1.7. The general time reversible nucleotide substitution model plus a gamma distribution among site rate heterogeneity model was the best substitution model for all sequence sets. Maximum likelihood (ML) trees were constructed using MEGA 7.0 with 1000 bootstrap replications. All ML phylogenetic trees were rooted with HCV 7a as an out-group. Reference sequences were downloaded from the Los Alamos National Laboratory HCV sequence database and International Committee on Taxonomy of Viruses. Pairwise nucleotide and amino acid similarities were calculated using software BioEdit v7.0. The recombination analysis was performed with SimPlot 3.5.1 software.</p><p>In order to estimate the phylogeny of HCV genotype 6 strains among patients in the China&#x02013;Myanmar border region, all available E1/E2 (H77: 933-2048) and NS5B sequences (H77: 8373-9215) of HCV genotype 6 were downloaded from GenBank. The E1/E2 dataset covers 93 sequences from Dehong (<italic>n</italic> = 90) and Lincang (<italic>n</italic> = 3), Yunnan province. The NS5B dataset includes 89 sequences from Dehong (<italic>n</italic> = 86) and Lincang (<italic>n</italic> = 3). These sequences were subjected to the phylogenetic analyses with the sequences obtained in this study.</p></sec><sec><title>Bayesian Phylogenetic Analysis</title><p>To explore the evolutionary history of HCV genotype 6 in the China&#x02013;Myanmar border region, the E1/E2 and NS5B sequences with known sampling years and sampling locations were subjected to the Bayesian analysis. The time to the most recent common ancestor (tMRCA) was inferred using the Markov Chain Monte Carlo (MCMC) algorithm as implemented in BEAST v1.10.0. Maximum clade credibility (MCC) trees were constructed under an uncorrelated relaxed lognormal molecular clock model, the general time reversible nucleotide substitution model plus a gamma distribution among site rate heterogeneity model and a constant population size coalescent model by BEAST v1.10.0. Each MCMC was run for 200 million generations and sampled every 20000 generations. Convergence was assessed on the basis of the effective sampling size (ESS) after a 25% burn-in using Tracer v1.7.1. Only ESS values &#x0003e; 200 were accepted. All of these trees were viewed and edited using FigTree v1.4.3. Population dynamics were constructed under a Bayesian skyline plot coalescent tree prior and a piecewise-linear skyline model with 10 groups by BEAST v1.10.0. The Bayesian skyline plot was reconstructed using Tracer v1.7.1.</p></sec><sec><title>Statistical Analysis</title><p>The statistical analysis was performed by statistical software Statistical Package for Social Sciences (version 19.0; SPSS, Inc., Chicago, IL, United States). The normality of distribution of continuous variable (age) was tested by one-sample Kolmogorov&#x02013;Smirnov test. Continuous variable with normal distribution was expressed as mean &#x000b1; standard deviation; non-normal variable was shown as median &#x000b1; interquartile range. Categorical variables were compared using Chi-square test. A value of <italic>P</italic> &#x0003c; 0.05 was considered statistically significant.</p></sec><sec><title>GenBank Accession Numbers</title><p>The nucleotide sequences reported in this study have been submitted to GenBank with accession numbers <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="MH458952">MH458952</ext-link>&#x02013;<ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="MH458976">MH458976</ext-link> for C/E2, MH458977&#x02013;MH459000 for NS5B and MH492360&#x02013;MH492362 for full-length genome.</p></sec></sec><sec><title>Results</title><sec><title>Social-Demographic Characteristics of IDUs in Kachin State, Myanmar</title><p>A total of 100 IDUs were recruited from Kachin State, Myanmar (<xref rid="T1" ref-type="table">Table 1</xref>). The participants were at a mean age of 37.3 &#x000b1; 13.0 years old. The majority of them were male (88.0%) and farmers (86.0%). Most IDUs were married (56.6%), were Jingpo ethnicity (55.6%), and completed their primary school or had higher level education (77.0%). Importantly, 79.6% of them had a history of cross-border migration between Myanmar and China.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic characteristics of study subjects.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><th valign="top" align="left" colspan="2" rowspan="1">Variable</th><th valign="top" align="center" colspan="2" rowspan="1">Total</th><th valign="top" align="center" colspan="2" rowspan="1">HCV seropositive</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic>-value</th></tr><tr><th valign="top" align="left" colspan="2" rowspan="1"/><th valign="top" align="center" colspan="2" rowspan="1"><hr/></th><th valign="top" align="center" colspan="2" rowspan="1"><hr/></th><th valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><th valign="top" align="left" colspan="2" rowspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><italic>N</italic></th><th valign="top" align="center" rowspan="1" colspan="1">%</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>n</italic></th><th valign="top" align="center" rowspan="1" colspan="1">%</th><th valign="top" align="center" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="left" colspan="2" rowspan="1">Gender</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.851</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Male</td><td valign="top" align="center" rowspan="1" colspan="1">88</td><td valign="top" align="center" rowspan="1" colspan="1">88.0</td><td valign="top" align="center" rowspan="1" colspan="1">36</td><td valign="top" align="center" rowspan="1" colspan="1">40.9</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Female</td><td valign="top" align="center" rowspan="1" colspan="1">12</td><td valign="top" align="center" rowspan="1" colspan="1">12.0</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">33.3</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Age</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.136</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">&#x02264;25</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">20.0</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">35.0</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">26&#x02013;35</td><td valign="top" align="center" rowspan="1" colspan="1">29</td><td valign="top" align="center" rowspan="1" colspan="1">29.0</td><td valign="top" align="center" rowspan="1" colspan="1">11</td><td valign="top" align="center" rowspan="1" colspan="1">37.9</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">36&#x02013;45</td><td valign="top" align="center" rowspan="1" colspan="1">28</td><td valign="top" align="center" rowspan="1" colspan="1">28.0</td><td valign="top" align="center" rowspan="1" colspan="1">16</td><td valign="top" align="center" rowspan="1" colspan="1">57.1</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">&#x02265;46</td><td valign="top" align="center" rowspan="1" colspan="1">23</td><td valign="top" align="center" rowspan="1" colspan="1">23.0</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">26.1</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Occupation</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.724</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Farmer</td><td valign="top" align="center" rowspan="1" colspan="1">86</td><td valign="top" align="center" rowspan="1" colspan="1">86.0</td><td valign="top" align="center" rowspan="1" colspan="1">35</td><td valign="top" align="center" rowspan="1" colspan="1">40.7</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Others<sup>a</sup></td><td valign="top" align="center" rowspan="1" colspan="1">14</td><td valign="top" align="center" rowspan="1" colspan="1">14.0</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">35.7</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Education</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.140</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">None</td><td valign="top" align="center" rowspan="1" colspan="1">23</td><td valign="top" align="center" rowspan="1" colspan="1">23.0</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">30.4</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Primary school</td><td valign="top" align="center" rowspan="1" colspan="1">43</td><td valign="top" align="center" rowspan="1" colspan="1">43.0</td><td valign="top" align="center" rowspan="1" colspan="1">22</td><td valign="top" align="center" rowspan="1" colspan="1">51.2</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Junior school or above</td><td valign="top" align="center" rowspan="1" colspan="1">34</td><td valign="top" align="center" rowspan="1" colspan="1">34.0</td><td valign="top" align="center" rowspan="1" colspan="1">11</td><td valign="top" align="center" rowspan="1" colspan="1">32.4</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Ethnicity<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.184</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Jingpo</td><td valign="top" align="center" rowspan="1" colspan="1">55</td><td valign="top" align="center" rowspan="1" colspan="1">55.6</td><td valign="top" align="center" rowspan="1" colspan="1">19</td><td valign="top" align="center" rowspan="1" colspan="1">34.5</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Others<sup>c</sup></td><td valign="top" align="center" rowspan="1" colspan="1">44</td><td valign="top" align="center" rowspan="1" colspan="1">44.4</td><td valign="top" align="center" rowspan="1" colspan="1">21</td><td valign="top" align="center" rowspan="1" colspan="1">47.7</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Marital status<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.214</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Unmarried</td><td valign="top" align="center" rowspan="1" colspan="1">38</td><td valign="top" align="center" rowspan="1" colspan="1">38.4</td><td valign="top" align="center" rowspan="1" colspan="1">16</td><td valign="top" align="center" rowspan="1" colspan="1">42.1</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Married</td><td valign="top" align="center" rowspan="1" colspan="1">56</td><td valign="top" align="center" rowspan="1" colspan="1">56.6</td><td valign="top" align="center" rowspan="1" colspan="1">24</td><td valign="top" align="center" rowspan="1" colspan="1">42.9</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Divorced or widowed</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">5.1</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Cross-border<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.107</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">78</td><td valign="top" align="center" rowspan="1" colspan="1">79.6</td><td valign="top" align="center" rowspan="1" colspan="1">35</td><td valign="top" align="center" rowspan="1" colspan="1">44.9</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">20.4</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">25.0</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Duration of drug abuse<sup>b</sup></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.027</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">&#x02264;5 years</td><td valign="top" align="center" rowspan="1" colspan="1">53</td><td valign="top" align="center" rowspan="1" colspan="1">54.6</td><td valign="top" align="center" rowspan="1" colspan="1">16</td><td valign="top" align="center" rowspan="1" colspan="1">30.2</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">&#x0003e;5 years</td><td valign="top" align="center" rowspan="1" colspan="1">44</td><td valign="top" align="center" rowspan="1" colspan="1">45.4</td><td valign="top" align="center" rowspan="1" colspan="1">23</td><td valign="top" align="center" rowspan="1" colspan="1">52.3</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><attrib><italic><sup><italic>a</italic></sup>Driver, Worker, Businessman, Jobless. <sup><italic>b</italic></sup>The information of questionnaires was incomplete. <sup><italic>c</italic></sup>Dai, Mian, Lisu, Han, Achang, Deang, Dong, Yi.</italic></attrib></table-wrap-foot></table-wrap><p>The HCV seroprevalence of this cohort was 40.0% (40/100). HCV prevalence was significantly associated with duration of drug use with higher positive rate among IDUs with longer duration (over 5 years) (52.3%) than those among IDUs with short duration of less than 5 years (30.2%) (<italic>P</italic> = 0.027), but not with gender, age, occupation, educational level, ethnicity, cross-border migration behavior, and marital status (<italic>P</italic> &#x0003e; 0.05) (<xref rid="T1" ref-type="table">Table 1</xref>).</p></sec><sec><title>HCV Genotyping of the Sequences From IDUs in Kachin State, Myanmar</title><p>We successfully amplified and sequenced 25 C/E2 and 24 NS5B fragments from 25 of 40 HCV positive samples. There were 24 samples with both C/E2 and NS5B sequences, and one sample with only C/E2 sequence. HCV subtypes were determined based on the C/E2 and NS5B ML trees (<xref ref-type="fig" rid="F2">Figure 2</xref>). Both ML trees showed completely consistent subtyping results for 24 samples with both C/E2 and NS5B sequences. Except four sequences (KS27, KS81, KS86, and KS88), all other sequences were able to be assigned to known HCV subtypes (<xref ref-type="fig" rid="F2">Figure 2</xref>). Five HCV subtypes 1a, 3a, 3b, 6n, and 6xa (previously known as 6u) were found among this cohort, and subtype 3b appeared to be the most predominant HCV genotype (24.0%), followed by subtypes 6xa (20.0%), 6n (16.0%), 1a (12.0%), and 3a (12.0%) (<xref rid="T2" ref-type="table">Table 2</xref>). Among four unassigned sequences, three (KS27, KS81, and KS86) clustered together, forming an independent clade between the clades of subtypes 6n and 6m (<xref ref-type="fig" rid="F2">Figure 2</xref>). The phylogenetic position of the clade in the trees was similar to the clade previously described (<xref rid="B37" ref-type="bibr">Wan et al., 2016</xref>), suggesting that these variants in this study and previous study may belong to a new subtype.</p><fig id="F2" position="float"><label>FIGURE 2</label><caption><p>Maximum likelihood trees of C/E2 <bold>(A)</bold> and NS5B <bold>(B)</bold> fragments of HCV strains in Kachin, Myanmar. The trees were constructed using MEGA 7.0 with ML method under the &#x0201c;GTR+I+G&#x0201d; model. The reliability of interior branches in the trees was evaluated by the bootstrap method with 1000 replications. Only bootstrap values over 75% are shown. The clade of the potential new HCV subtype is highlighted by an arrow.</p></caption><graphic xlink:href="fmicb-10-00814-g002"/></fig><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>The genotypes distribution of HCV among IDUs in Kachin, Myanmar.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Genomic fragment</th><th valign="top" align="center" colspan="6" rowspan="1">HCV subtype n (%)</th><th valign="top" align="center" rowspan="1" colspan="1">Total (n)</th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="left" colspan="6" rowspan="1"><hr/></th><th valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">1a</th><th valign="top" align="center" rowspan="1" colspan="1">3a</th><th valign="top" align="center" rowspan="1" colspan="1">3b</th><th valign="top" align="center" rowspan="1" colspan="1">6n</th><th valign="top" align="center" rowspan="1" colspan="1">6xa</th><th valign="top" align="center" rowspan="1" colspan="1">Potential new subtypes</th><th valign="top" align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">C/E2</td><td valign="top" align="center" rowspan="1" colspan="1">3 (12.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (12.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (24.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (16.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (20.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (16.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">25</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">NS5B</td><td valign="top" align="center" rowspan="1" colspan="1">3 (12.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (12.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (25.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (16.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">24</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">C/E2 and or NS5B</td><td valign="top" align="center" rowspan="1" colspan="1">3 (12.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (12.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (24.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (16.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (20.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (16.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">25</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></sec><sec><title>Identification of the HCV New Subtype 6xg</title><p>To identify and confirm the new HCV subtype, we obtained the near full-length genomic sequences of the three isolates KS27, KS81, and KS86 by amplifying and sequencing 10 overlapping HCV genomic fragments. Their genomes were composed of 9318 nt, including the 5&#x02032;UTR (nt 1&#x02013;272) and a single open reading frame (nt 273&#x02013;9318) encoding a polyprotein precursor of 3015 amino acids. The protein coding region consisted of the core (573 nt/191 aa), E1 (576 nt/192 aa), E2 (1092 nt/364 aa), P7 (189 nt/63 aa), NS2 (651 nt/217 aa), NS3 (1893 nt/631 aa), NS4A (162 nt/54 aa), NS4B (783 nt/261 aa), NS5A (1356 nt/452 aa) and NS5B (1771 nt/590 aa) (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table S2</xref>).</p><p>Phylogenetic analysis of the full-length genomic sequences showed that the three strains closely clustered together, forming an independent clade with 100% bootstrap value support (<xref ref-type="fig" rid="F3">Figure 3A</xref>). The clade was clustered with the clade of subtype 6n, indicating an early divergence from subtype 6n. Sequence analyses showed that the three strains had nucleotide similarities of 96.1&#x02013;99.3% each other, and average similarities of 71.8&#x02013;85.6% with other subtypes of the genotype 6 (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table S3</xref>). In addition, no recombination breakpoint was detected within the three sequences. Because the sequences that were obtained from three epidemiologically unrelated individuals met the criteria of a new HCV subtype, they were assigned as new HCV subtype 6xg in alphabetical order. Compared to other subtypes of HCV genotype 6, the 6xg strains had a one-amino acid (Lys) insertion in the RRKR/K motif of NS5A (<xref ref-type="fig" rid="F3">Figure 3B</xref>).</p><fig id="F3" position="float"><label>FIGURE 3</label><caption><p>Identification of the new HCV subtype 6xg. <bold>(A)</bold> ML tree of 3 representative full-length genomic sequences. <bold>(B)</bold> NS5A sequence feature of HCV subtype 6xg.</p></caption><graphic xlink:href="fmicb-10-00814-g003"/></fig></sec><sec><title>Epidemiological Distribution of HCV Subtype 6xg in the China&#x02013;Myanmar Border Region</title><p>To explore the prevalence of the new HCV subtype 6xg in the China&#x02013;Myanmar border region, we performed HCV BLAST using 6xg reference sequences obtained in this study as the query set. The top hit sequences were subjected to further phylogenetic analyses. Except the three reference sequences, 16 additional E1E2 and/or NS5B sequences were found to cluster within the clade of the subtype 6xg. The 16 strains were mainly isolated from Dehong prefecture (including Longchuan and Yingjiang counties), including 12 strains previously isolated from Burmese IDUs staying in Yunnan) (<xref ref-type="fig" rid="F4">Figure 4</xref>) (<xref rid="B47" ref-type="bibr">Xia et al., 2008</xref>; <xref rid="B3" ref-type="bibr">Chen et al., 2015</xref>; <xref rid="B37" ref-type="bibr">Wan et al., 2016</xref>). The earliest strain of the subtype 6xg was traced to a sample (DH095) in 2002 (<xref rid="B47" ref-type="bibr">Xia et al., 2008</xref>), which belongs to subtype 6xg at least in NS5B region (<xref ref-type="fig" rid="F4">Figure 4B</xref>). These results indicate that HCV subtype 6xg has had a regional epidemic in the China&#x02013;Myanmar border region since 2002.</p><fig id="F4" position="float"><label>FIGURE 4</label><caption><p>ML trees of E1/E2 <bold>(A)</bold> and NS5B <bold>(B)</bold> sequences using hit sequences. The hit sequences were obtained by HCV BLAST with HCV 6xg strains as query set. The clades of subtypes 6xg, 6xe, and 6n are highlighted by green, yellow, and red shadows, respectively. The sequences from the Burmese IDUs staying in Yunnan are highlighted by blue stars, and the strain isolated in 2002 is highlighted by a blue triangle. NA indicates that the nationality of IDUs is not available.</p></caption><graphic xlink:href="fmicb-10-00814-g004"/></fig><p>We then compared the subtype distributions among Kachin, Dehong, Kunming, Honghe and Wenshan, and Yangon (<xref ref-type="fig" rid="F1">Figure 1</xref>). We found that HCV subtype pattern in Kachin was very similar to that in Dehong, but very distinct from those in other regions. Apart from 6xg, HCV 6xa was also mainly prevalent in Kachin and Dehong, but rare in other regions. In contrast, HCV subtypes 6m prevalent in Yangon, and 6a prevalent in Kunming, Honghe and Wenshan, were rarely detected in Kachin and Dehong. Furthermore, the most common subtype 1b was also rarely detected in Kachin and Dehong. These results indicated that the China&#x02013;Myanmar border region had a different HCV subtype pattern from other regions (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p></sec><sec><title>Evolutionary History of HCV Subtype 6xg</title><p>To investigate the origin time of the new HCV subtype 6xg, Bayesian phylogenetic analyses were performed. The MCC trees showed consistent topological structures with the ML trees (<xref ref-type="fig" rid="F3">Figure 3</xref>&#x02013;<xref ref-type="fig" rid="F5">5</xref>). The tMRCAs of the subtype 6xg were inferred to be 1984.4 (95% CI: 1965.7&#x02013;1997.6) and 1988.0 (95% CI: 1970.5&#x02013;2000.1) based on E1E2 and NS5B genomic regions, respectively (<xref ref-type="fig" rid="F5">Figure 5</xref>), suggesting that subtype 6xg originated during 1984&#x02013;1988. The origin times of two genetically related subtypes 6n and 6xe were inferred to be 1914&#x02013;1925 and 1986&#x02013;2000, respectively. We then simulated the population dynamics of the subtype 6xg by Bayesian skyline plot analysis of NS5B sequences. A fast exponential growth of the subtype 6xg was observed during 2005&#x02013;2009, followed by a stable population size (<xref ref-type="fig" rid="F6">Figure 6</xref>).</p><fig id="F5" position="float"><label>FIGURE 5</label><caption><p>The maximum clade credibility trees of E1/E2 <bold>(A)</bold> and NS5B <bold>(B)</bold> fragments. The MCC trees were obtained by Bayesian MCMC analysis based on partial E1/E2 and NS5B sequences. The nodes of HCV subtype 6n, 6xe, and 6xg clades are shown using black dots. The node ages with 95% confidence interval are shown beside the nodes.</p></caption><graphic xlink:href="fmicb-10-00814-g005"/></fig><fig id="F6" position="float"><label>FIGURE 6</label><caption><p>Bayesian skyline plot estimated the past population dynamics of HCV 6xg among IDUs. The <italic>y</italic>-axis represents the estimates of the effective number of HCV 6xg strains and the <italic>x</italic>-axis represents time. The solid line represents the median estimate and the shaded area represents the 95% confidence intervals.</p></caption><graphic xlink:href="fmicb-10-00814-g006"/></fig></sec></sec><sec><title>Discussion</title><p>Hepatitis C virus genetic diversity influences its biology (e.g., infectivity, transmissibility and immunogenicity), diagnosis, vaccine development and response to antiviral therapy (<xref rid="B48" ref-type="bibr">Zein, 2000</xref>; <xref rid="B17" ref-type="bibr">Legrand-Abravanel et al., 2009</xref>). Characterizing HCV genetic diversity may provide valuable insights into diagnosis, prevention and therapy of HCV infection. One important finding of this study is the identification of the new HCV subtype 6xg, which increases the subtype number of the genotype 6 to 31 (6a-6xh) together with another new subtype 6xh (<xref rid="B46" ref-type="bibr">Wu et al., 2018</xref>).</p><p>Currently, eight HCV genotypes and 86 subtypes were classified (<xref rid="B32" ref-type="bibr">Smith et al., 2014</xref>; <xref rid="B2" ref-type="bibr">Borgia et al., 2018</xref>). Different HCV genotypes displayed distinct epidemiological profiles (<xref rid="B9" ref-type="bibr">Gower et al., 2014</xref>; <xref rid="B27" ref-type="bibr">Messina et al., 2015</xref>). The genotype 1 is globally epidemic, while the others are generally restricted to specific geographical regions: the genotypes 2 and 3 are primarily prevalent in Asia and Europe, the genotypes 4 and 5 in Africa, and the genotype 6 appears to be restricted to Southeast Asia (<xref rid="B9" ref-type="bibr">Gower et al., 2014</xref>; <xref rid="B27" ref-type="bibr">Messina et al., 2015</xref>). Relative to other HCV genotypes, the genotype 6 is more diverse and has diverged into multiple different subtypes, including 31 confirmed subtypes, as well as some unassigned variants (<xref rid="B32" ref-type="bibr">Smith et al., 2014</xref>; <xref rid="B34" ref-type="bibr">Thong et al., 2014</xref>; <xref rid="B46" ref-type="bibr">Wu et al., 2018</xref>). As a new subtype, HCV 6xg is more genetically related to the subtypes 6n and 6xe (<xref ref-type="fig" rid="F3">Figure 3A</xref>) and is estimated to have originated during 1984&#x02013;1988 (<xref ref-type="fig" rid="F5">Figure 5</xref>). Although the three representative full-length genomic sequences were isolated from IDUs in Kachin, Myanmar, it remains difficult to determine where the subtype 6xg arose because more 6xg sequences were found among IDUs in Dehong prefecture of Yunnan (<xref ref-type="fig" rid="F4">Figure 4</xref>). In spite of this, the appearance of this new subtype among IDUs in the China&#x02013;Myanmar border region could have significant epidemiological and public health implications.</p><p>Hepatitis C virus genotype 6 was mainly circulating in southwest China and other Southeast Asian countries (e.g., Myanmar, Vietnam, Thailand, and Laos) (<xref rid="B9" ref-type="bibr">Gower et al., 2014</xref>; <xref rid="B34" ref-type="bibr">Thong et al., 2014</xref>; <xref rid="B27" ref-type="bibr">Messina et al., 2015</xref>). Although 31 HCV 6 subtypes had been identified, only few subtypes (e.g., 6a, 6n, 6m, 6xa, and 6xg) caused epidemics (<xref rid="B34" ref-type="bibr">Thong et al., 2014</xref>; <xref rid="B46" ref-type="bibr">Wu et al., 2018</xref>). The subtype 6n was prevalent in China, Myanmar and other Southeast Asian countries (e.g., Thailand, Malaysia), while the subtype 6a was mainly circulating among IDUs in the south part of China, including Yunnan (<xref rid="B49" ref-type="bibr">Zhang et al., 2011</xref>, <xref rid="B51" ref-type="bibr">2013</xref>; <xref rid="B3" ref-type="bibr">Chen et al., 2015</xref>; <xref rid="B30" ref-type="bibr">Qi et al., 2016</xref>; <xref rid="B37" ref-type="bibr">Wan et al., 2016</xref>), and the subtype 6m was mainly found in blood donors of Myanmar and Thailand (<xref rid="B31" ref-type="bibr">Shinji et al., 2004</xref>; <xref rid="B16" ref-type="bibr">Jutavijittum et al., 2009</xref>; <xref rid="B39" ref-type="bibr">Wasitthankasem et al., 2015</xref>). Interestingly, the prevalence of subtypes 6xa and 6xg were restricted to the China&#x02013;Myanmar border region (<xref rid="B25" ref-type="bibr">Lwin et al., 2007</xref>; <xref rid="B51" ref-type="bibr">Zhang et al., 2013</xref>; <xref rid="B3" ref-type="bibr">Chen et al., 2015</xref>; <xref rid="B43" ref-type="bibr">Win et al., 2016</xref>). As a newly identified subtype, 6xg accounted for 12.0% (3/25) of all strains sampled in Kachin, and 6.0% (15/249) in Dehong prefecture, indicating that 6xg has become the main genotype 6 strains circulating in the China&#x02013;Myanmar border region after the subtypes 6n and 6xa (<xref ref-type="fig" rid="F1">Figure 1</xref>). The rapidly increasing prevalence of the 6xg strains occurred during 2005&#x02013;2009 as reflected by the population growth curve (<xref ref-type="fig" rid="F6">Figure 6</xref>). It is unclear if the increasing prevalence of this strain in the region represents a high transmissibility of the new subtype 6xg or circulation within a susceptible high risk group. The subtype 6xg diverged from the subtype 6n (<xref ref-type="fig" rid="F3">Figure 3A</xref>). It is clear, however, that compared to 6n and other subtypes of the genotype 6, 6xg had a one-amino acid insertion (Lys at position 360) in the RRKR/K motif of NS5A, which changes this motif to RRKKR/K (<xref ref-type="fig" rid="F3">Figure 3B</xref>). NS5A is a zinc-containing phosphoprotein involved in multiple and diverse functions in HCV replication, interferon resistance, and pathogenesis (<xref rid="B33" ref-type="bibr">Tellinghuisen et al., 2005</xref>; <xref rid="B10" ref-type="bibr">He et al., 2006</xref>), and the RRKR motif serves as a specific cleavage site for the furin family of intracellular proteinases (<xref rid="B29" ref-type="bibr">Pei and Weiss, 1995</xref>). Whether and how the Lys insertion influences the function of NS5A need to be experimentally investigated.</p><p>The China&#x02013;Myanmar border region was the worst-hit region by HCV and HIV-1, where IDU was the most high-risk behavior for infection with both viruses (<xref rid="B50" ref-type="bibr">Zhang et al., 2002</xref>; <xref rid="B52" ref-type="bibr">Zhou et al., 2011</xref>, <xref rid="B53" ref-type="bibr">2012</xref>; <xref rid="B19" ref-type="bibr">Li et al., 2014</xref>). HCV genetic diversity among IDUs in Yunnan had been extensively studied (<xref rid="B47" ref-type="bibr">Xia et al., 2008</xref>; <xref rid="B51" ref-type="bibr">Zhang et al., 2013</xref>; <xref rid="B3" ref-type="bibr">Chen et al., 2015</xref>; <xref rid="B37" ref-type="bibr">Wan et al., 2016</xref>), and three HCV genotypes (1, 3, and 6), including nine subtypes (1a, 1b, 3a, 3b, 6a, 6n, 6v, 6xa, and 6xg), were reported to be prevalent among IDUs in Yunnan (<xref ref-type="fig" rid="F1">Figure 1</xref>). However, HCV genetic diversity among IDUs in Myanmar was less concerned in spite of high HCV prevalence among this cohort. In this study, we characterized HCV genetic diversity among IDUs in Kachin, Myanmar (<xref ref-type="fig" rid="F1">Figure 1</xref>). Three HCV genotypes (1, 3, and 6), including six subtypes (1a, 3a, 3b, 6n, 6xa, and 6xg), as well as an unassigned genotype 6 variant, were detected among this cohort. The subtype distribution among IDUs was similar to that among IDUs in Dehong, another side of the border, but very distinct from those among general population (e.g., blood donors) in Myanmar and among IDUs in other regions of Yunnan (e.g., Kunming and Honghe) (<xref ref-type="fig" rid="F1">Figure 1</xref>). The main difference was that the subtypes 6xg and 6xa appeared to be mainly prevalent among IDUs in the China&#x02013;Myanmar border region. In contrast, there were rare strains from the subtypes 6a and 6m in this region, which had high prevalence in other regions of Yunnan and Myanmar, respectively (<xref ref-type="fig" rid="F1">Figure 1</xref>). Furthermore, the most common HCV subtype 1b was also rarely detected among IDUs in this region. These results suggest that the China&#x02013;Myanmar border region had a unique pattern of HCV genetic diversity among IDUs.</p><p>In China, pegylated interferon (PEG-IFN) plus ribavirin (RBV) (PEG-IFN+RBV) are recommended as a pan-genotypic regimen for HCV infection (<xref rid="B41" ref-type="bibr">Wei and Hou, 2015</xref>; <xref rid="B6" ref-type="bibr">Chen et al., 2018</xref>). The combination of sofosbuvir (SOF) and daclatasvir (DCV) is recommended in Myanmar (<xref rid="B28" ref-type="bibr">Ministry of Health and Sports Myanmar, 2017</xref>). Different direct-acting antiviral (DAA) therapies appeared to have various sustained virologic response (SVR) for different HCV genotypes. A systematic review and meta-analysis revealed that SVR of the PEG-IFN+RBV regimen to HCV genotype 6 was similar to genotypes 2 and 3, but higher than genotype 1 (<xref rid="B35" ref-type="bibr">Thong et al., 2015</xref>). The safety and efficacy of SOF-based DAA regimens for treatment of HCV genotype 6 were well demonstrated by some studies conducted in China and the United States (<xref rid="B44" ref-type="bibr">Wong et al., 2017</xref>; <xref rid="B14" ref-type="bibr">Hu et al., 2018</xref>; <xref rid="B45" ref-type="bibr">Wu et al., 2019</xref>). In particular, no significant difference in efficacy of SOF-based DAA regimens was observed between genotype 6 and genotypes 1-4, except for the combination of SOF and ledipasvir (LDV), which had lower SVR for genotype 6 than genotype 1 (<xref rid="B13" ref-type="bibr">Horner and Naggie, 2015</xref>; <xref rid="B12" ref-type="bibr">Hlaing et al., 2017</xref>; <xref rid="B8" ref-type="bibr">Fan et al., 2018</xref>; <xref rid="B14" ref-type="bibr">Hu et al., 2018</xref>). Furthermore, there was no study to compare the efficacy of various DAA regimens on different subtypes or variants of genotype 6.</p><p>Early drug trafficking and current labor migration from Myanmar to Yunnan driven by rapid economic development in China facilitate the cross-border transmissions of IDU-associated infectious diseases (e.g., HIV-1 and HCV) in the China&#x02013;Myanmar border region (<xref rid="B1" ref-type="bibr">Beyrer et al., 2000</xref>; <xref rid="B20" ref-type="bibr">Liu et al., 2012</xref>; <xref rid="B3" ref-type="bibr">Chen et al., 2015</xref>, <xref rid="B5" ref-type="bibr">2018b</xref>). As a China&#x02013;Myanmar border prefecture, Dehong serves as an important &#x0201c;hub&#x0201d; not only linking China and Myanmar, but also mediating viral transmission (<xref rid="B3" ref-type="bibr">Chen et al., 2015</xref>, <xref rid="B4" ref-type="bibr">2018a</xref>,<xref rid="B5" ref-type="bibr">b</xref>). Currently, Dehong has a large number of Burmese (including IDUs) who live, work or stay here. Increasing evidences suggested that Burmese IDUs staying in Yunnan played a crucial role in the cross-border transmission of IDU-associated viruses in spite that they were separated from the local IDUs to some extent (<xref rid="B37" ref-type="bibr">Wan et al., 2016</xref>; <xref rid="B4" ref-type="bibr">Chen et al., 2018a</xref>,<xref rid="B5" ref-type="bibr">b</xref>). Apart from the three strains identified in Kachin, Myanmar in this study, most other 6xg strains were found among Burmese IDUs staying in Dehong prefecture, and two strains were detected from Chinese IDUs, supporting a transmission link between Burmese and Chinese IDUs. Importantly, the fact of many 6xg-carring Burmese IDUs staying in Dehong will increase the possibility of 6xg causing epidemic outbreak among Chinese IDUs. The same concern was from HCV 6xa, which originated earlier in Myanmar (data not shown), and had caused epidemic outbreak among IDUs in both sides of the China-Myanmar border and sporadic outbreak in other regions of China (<xref rid="B30" ref-type="bibr">Qi et al., 2016</xref>; <xref rid="B37" ref-type="bibr">Wan et al., 2016</xref>). Given previous epidemiologic and transmission patterns of HIV-1, it is likely that HCV 6xg and 6xa spread from the border region to other regions of both China and Myanmar, and even across Southeast Asia. Therefore, closely monitoring the molecular epidemiology of HCV genotype 6 in this region and strengthening the management of Burmese IDUs staying in Yunnan are highly encouraged.</p><p>This study has several limitations. Frist, HCV exists in a quasispecies form in human body (<xref rid="B26" ref-type="bibr">Martell et al., 1992</xref>). It will be better to obtain a single full-length genome sequence from a single virus. However, because of failure in amplification of near full-length HCV genome (&#x0003e;5000 bps), we amplified and sequenced 10 overlapping HCV genomic segments to obtain the whole genome sequence. Therefore, the genomic sequences obtained in this study contain some ambiguous (or degenerate) nucleotides (quasispecies population). Second, previous studies showed that vast majority of IDUs in Yunnan, especially in the China-Myanmar border area, were male (<xref rid="B52" ref-type="bibr">Zhou et al., 2011</xref>, <xref rid="B53" ref-type="bibr">2012</xref>; <xref rid="B19" ref-type="bibr">Li et al., 2014</xref>; <xref rid="B5" ref-type="bibr">Chen et al., 2018b</xref>). Similarly, only few female IDUs&#x02019; samples were available in this study. Although no significant difference in HCV positive rate was observed between male and female IDUs (<xref rid="T1" ref-type="table">Table 1</xref>), we were unable to determine whether the gender has an effect on demographic characteristics and HCV subtype distribution due to relatively small sample size of female IDUs. Third, in addition to the identification of HCV 6xg, we found that the strain KS88 might also be a potential new subtype of HCV genotype 6. Because only one sample was found to carry this strain, which did not meet the criterion that the virus strain of a new subtype must be identified in at least three epidemiologically unlinked individuals, we did not perform further analysis of this strain. Whether the strain KS88 is a new HCV subtype needs to be determined by expanding the sample size in future study.</p><p>In summary, we firstly identified a new HCV subtype 6xg, and reported the molecular epidemiological characteristics of HCV among IDUs in Kachin, Myanmar. The appearance of 6xg and the unique HCV subtype profile in the China&#x02013;Myanmar border region have significant epidemiological and public health implications.</p></sec><sec><title>Ethics Statement</title><p>This is to confirm that the research protocol of the study entitled &#x0201c;Identification of a new HCV subtype 6xg among injection drug users in Kachin, Myanmar&#x0201d; (Principal investigator: Y-TZ), which has been reviewed and approved by the internal review board of Kunming Institute of Zoology, Chinese Academy of Sciences (approval number: SWYX-2013023; approval date: September 6, 2013).</p></sec><sec><title>Author Contributions</title><p>Y-TZ, CZ, and MY contributed to conception, designed the study, and interpreted the results. LD and XC collected the samples. MY and YW performed the experiments. MY analyzed the data. Y-TZ, CZ, and MY wrote the manuscript. Y-TZ supervised the study. All authors read the manuscript and approved the submitted version.</p></sec><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported in part by grants from the National Natural Science Foundation of China (U1302224, 81601802 and 81271892).</p></fn></fn-group><ack><p>We would like to thank the staffs of Yundi Behavior and Health Research Center for their assistance in collecting the blood samples. We would also like to thank all the participants who participated in this research.</p></ack><fn-group><fn id="fn01"><label>1</label><p><ext-link ext-link-type="uri" xlink:href="https://talk.ictvonline.org/ictv_wikis/flaviviridae/w/Sg_flavi/56/hcv-classification">https://talk.ictvonline.org/ictv_wikis/flaviviridae/w/Sg_flavi/56/hcv-classification</ext-link></p></fn><fn id="fn02"><label>2</label><p><ext-link ext-link-type="uri" xlink:href="https://hcv.lanl.gov/content/sequence/VIRALIGN/viralign.html">https://hcv.lanl.gov/content/sequence/VIRALIGN/viralign.html</ext-link></p></fn></fn-group><sec sec-type="supplementary material"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2019.00814/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmicb.2019.00814/full#supplementary-material</ext-link></p><supplementary-material content-type="local-data" id="SM1"><media xlink:href="Table_1.DOCX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beyrer</surname><given-names>C.</given-names></name><name><surname>Razak</surname><given-names>M. H.</given-names></name><name><surname>Lisam</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Lui</surname><given-names>W.</given-names></name><name><surname>Yu</surname><given-names>X. F.</given-names></name></person-group> (<year>2000</year>). <article-title>Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia.</article-title>
<source><italic>AIDS</italic></source>
<volume>14</volume>
<fpage>75</fpage>&#x02013;<lpage>83</lpage>. <?supplied-pmid 10714570?><pub-id pub-id-type="pmid">10714570</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borgia</surname><given-names>S. M.</given-names></name><name><surname>Hedskog</surname><given-names>C.</given-names></name><name><surname>Parhy</surname><given-names>B.</given-names></name><name><surname>Hyland</surname><given-names>R. H.</given-names></name><name><surname>Stamm</surname><given-names>L. M.</given-names></name><name><surname>Brainard</surname><given-names>D. M.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Identification of a novel Hepatitis C virus genotype from Punjab, India: expanding classification of Hepatitis C virus into 8 genotypes.</article-title>
<source><italic>J. Infect. Dis.</italic></source>
<volume>218</volume>
<fpage>1722</fpage>&#x02013;<lpage>1729</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiy401</pub-id>
<?supplied-pmid 29982508?><pub-id pub-id-type="pmid">29982508</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Luo</surname><given-names>H.</given-names></name><name><surname>Dai</surname><given-names>J.</given-names></name><name><surname>Song</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Multiple introduction and naturally occuring drug resistance of HCV among HIV-infected intravenous drug users in Yunnan: an origin of China&#x02019;s HIV/HCV epidemics.</article-title>
<source><italic>PLoS One</italic></source>
<volume>10</volume>:<issue>e0142543</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0142543</pub-id>
<?supplied-pmid 26562015?><pub-id pub-id-type="pmid">26562015</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Duo</surname><given-names>L.</given-names></name><name><surname>Ye</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Zheng</surname><given-names>Y. T.</given-names></name></person-group> (<year>2018a</year>). <article-title>Non-Chinese immigrants: challenge faced by Yunnan of China to achieve the 90-90-90 goals.</article-title>
<source><italic>Virol. Sin.</italic></source>
<volume>33</volume>
<fpage>291</fpage>&#x02013;<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1007/s12250-018-0038-x</pub-id>
<?supplied-pmid 29931513?><pub-id pub-id-type="pmid">29931513</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>Y. H.</given-names></name><name><surname>Ye</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Duo</surname><given-names>L.</given-names></name><name><surname>Pang</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2018b</year>). <article-title>Burmese injecting drug users in Yunnan play a pivotal role in the cross-border transmission of HIV-1 in the China-Myanmar border region.</article-title>
<source><italic>Virulence</italic></source>
<volume>9</volume>
<fpage>1195</fpage>&#x02013;<lpage>1204</lpage>. <pub-id pub-id-type="doi">10.1080/21505594.2018.1496777</pub-id>
<?supplied-pmid 30001176?><pub-id pub-id-type="pmid">30001176</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z. W.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>Q. H.</given-names></name><name><surname>Wu</surname><given-names>X. L.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Ren</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Large disparity between prevalence and treatment rates for Hepatitis C in Western China.</article-title>
<source><italic>J. Clin. Transl. Hepatol.</italic></source>
<volume>6</volume>
<fpage>385</fpage>&#x02013;<lpage>390</lpage>. <pub-id pub-id-type="doi">10.14218/jcth.2018.00027</pub-id>
<?supplied-pmid 30637215?><pub-id pub-id-type="pmid">30637215</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Degenhardt</surname><given-names>L.</given-names></name><name><surname>Peacock</surname><given-names>A.</given-names></name><name><surname>Colledge</surname><given-names>S.</given-names></name><name><surname>Leung</surname><given-names>J.</given-names></name><name><surname>Grebely</surname><given-names>J.</given-names></name><name><surname>Vickerman</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.</article-title>
<source><italic>Lancet Glob. Health</italic></source>
<volume>5</volume>
<fpage>e1192</fpage>&#x02013;<lpage>e1207</lpage>. <pub-id pub-id-type="doi">10.1016/s2214-109x(17)30375-3</pub-id>
<?supplied-pmid 29074409?><pub-id pub-id-type="pmid">29074409</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>P.</given-names></name><name><surname>Tian</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Xia</surname><given-names>X.</given-names></name><name><surname>Feng</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Efficacy and safety of sofosbuvir-containing regimens in chronic Hepatitis C patients with genotype 2 and 3: a comprehensive analysis of 18 randomized controlled trials.</article-title>
<source><italic>J. Gastrointestin. Liver Dis.</italic></source>
<volume>27</volume>
<fpage>159</fpage>&#x02013;<lpage>168</lpage>. <pub-id pub-id-type="doi">10.15403/jgld.2014.1121.272.sof</pub-id>
<?supplied-pmid 29922761?><pub-id pub-id-type="pmid">29922761</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gower</surname><given-names>E.</given-names></name><name><surname>Estes</surname><given-names>C.</given-names></name><name><surname>Blach</surname><given-names>S.</given-names></name><name><surname>Razavi-Shearer</surname><given-names>K.</given-names></name><name><surname>Razavi</surname><given-names>H.</given-names></name></person-group> (<year>2014</year>). <article-title>Global epidemiology and genotype distribution of the Hepatitis C virus infection.</article-title>
<source><italic>J. Hepatol.</italic></source>
<volume>61</volume>
<fpage>S45</fpage>&#x02013;<lpage>S57</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhep.2014.07.027</pub-id>
<?supplied-pmid 25086286?><pub-id pub-id-type="pmid">25086286</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Staschke</surname><given-names>K. A.</given-names></name><name><surname>Tan</surname><given-names>S. L.</given-names></name></person-group> (<year>2006</year>). <article-title>&#x0201c;HCV NS5A: a multifunctional regulator of cellular pathways and virus replication,&#x0201d; in</article-title>
<source><italic>Hepatitis C Viruses: Genomes and Molecular Biology</italic></source>, <role>ed.</role>
<person-group person-group-type="editor"><name><surname>Tan</surname><given-names>S. L.</given-names></name></person-group> (<publisher-loc>Norfolk</publisher-loc>: <publisher-name>Horizon Scientific Press</publisher-name>), <fpage>267</fpage>&#x02013;<lpage>292</lpage>.</mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname><given-names>Y. A.</given-names></name><name><surname>Deeks</surname><given-names>E. D.</given-names></name></person-group> (<year>2018</year>). <article-title>Sofosbuvir/Velpatasvir/Voxilaprevir: a review in chronic Hepatitis C.</article-title>
<source><italic>Drugs</italic></source>
<volume>78</volume>
<fpage>577</fpage>&#x02013;<lpage>587</lpage>. <pub-id pub-id-type="doi">10.1007/s40265-018-0895-5</pub-id>
<?supplied-pmid 29546556?><pub-id pub-id-type="pmid">29546556</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hlaing</surname><given-names>N. K. T.</given-names></name><name><surname>Mitrani</surname><given-names>R. A.</given-names></name><name><surname>Aung</surname><given-names>S. T.</given-names></name><name><surname>Phyo</surname><given-names>W. W.</given-names></name><name><surname>Serper</surname><given-names>M.</given-names></name><name><surname>Kyaw</surname><given-names>A. M. M.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for Hepatitis C virus genotypes 1-4 and 6 in Myanmar: real-world experience.</article-title>
<source><italic>J. Viral Hepat.</italic></source>
<volume>24</volume>
<fpage>927</fpage>&#x02013;<lpage>935</lpage>. <pub-id pub-id-type="doi">10.1111/jvh.12721</pub-id>
<?supplied-pmid 28475232?><pub-id pub-id-type="pmid">28475232</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horner</surname><given-names>S. M.</given-names></name><name><surname>Naggie</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Successes and challenges on the road to cure Hepatitis C.</article-title>
<source><italic>PLoS Pathog.</italic></source>
<volume>11</volume>:<issue>e1004854</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1004854</pub-id>
<?supplied-pmid 26087286?><pub-id pub-id-type="pmid">26087286</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>C.</given-names></name><name><surname>Yuan</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Ren</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Sofosbuvir-based therapies for patients with Hepatitis C virus infection: real-world experience in China.</article-title>
<source><italic>Can. J. Gastroenterol. Hepatol.</italic></source>
<volume>2018</volume>:<issue>3908767</issue>. <pub-id pub-id-type="doi">10.1155/2018/3908767</pub-id>
<?supplied-pmid 30538973?><pub-id pub-id-type="pmid">30538973</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubschen</surname><given-names>J. M.</given-names></name><name><surname>Jutavijittum</surname><given-names>P.</given-names></name><name><surname>Thammavong</surname><given-names>T.</given-names></name><name><surname>Samountry</surname><given-names>B.</given-names></name><name><surname>Yousukh</surname><given-names>A.</given-names></name><name><surname>Toriyama</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>High genetic diversity including potential new subtypes of hepatitis C virus genotype 6 in Lao People&#x02019;s Democratic Republic.</article-title>
<source><italic>Clin. Microbiol. Infect.</italic></source>
<volume>17</volume>
<fpage>E30</fpage>&#x02013;<lpage>E34</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-0691.2011.03665.x</pub-id>
<?supplied-pmid 21958219?><pub-id pub-id-type="pmid">21958219</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jutavijittum</surname><given-names>P.</given-names></name><name><surname>Jiviriyawat</surname><given-names>Y.</given-names></name><name><surname>Yousukh</surname><given-names>A.</given-names></name><name><surname>Pantip</surname><given-names>C.</given-names></name><name><surname>Maneekarn</surname><given-names>N.</given-names></name><name><surname>Toriyama</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Genotypic distribution of Hepatitis C virus in voluntary blood donors of northern Thailand.</article-title>
<source><italic>Southeast Asian J. Trop. Med. Public Health</italic></source>
<volume>40</volume>
<fpage>471</fpage>&#x02013;<lpage>479</lpage>. <?supplied-pmid 19842432?><pub-id pub-id-type="pmid">19842432</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legrand-Abravanel</surname><given-names>F.</given-names></name><name><surname>Colson</surname><given-names>P.</given-names></name><name><surname>Leguillou-Guillemette</surname><given-names>H.</given-names></name><name><surname>Alric</surname><given-names>L.</given-names></name><name><surname>Ravaux</surname><given-names>I.</given-names></name><name><surname>Lunel-Fabiani</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy.</article-title>
<source><italic>J. Med. Virol.</italic></source>
<volume>81</volume>
<fpage>2029</fpage>&#x02013;<lpage>2035</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.21583</pub-id>
<?supplied-pmid 19856464?><pub-id pub-id-type="pmid">19856464</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Barnes</surname><given-names>E.</given-names></name><name><surname>Newton</surname><given-names>P. N.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Vongsouvath</surname><given-names>M.</given-names></name><name><surname>Klenerman</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>An expanded taxonomy of Hepatitis C virus genotype 6: characterization of 22 new full-length viral genomes.</article-title>
<source><italic>Virology</italic></source>
<volume>476</volume>
<fpage>355</fpage>&#x02013;<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2014.12.025</pub-id>
<?supplied-pmid 25589238?><pub-id pub-id-type="pmid">25589238</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Assanangkornchai</surname><given-names>S.</given-names></name><name><surname>Duo</surname><given-names>L.</given-names></name><name><surname>Mcneil</surname><given-names>E.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Risk behaviors, prevalence of HIV and Hepatitis C virus infection and population size of current injection drug users in a China-Myanmar border city: results from a respondent-driven sampling survey in 2012.</article-title>
<source><italic>PLoS One</italic></source>
<volume>9</volume>:<issue>e106899</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0106899</pub-id>
<?supplied-pmid 25203256?><pub-id pub-id-type="pmid">25203256</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Jia</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>Q.</given-names></name><name><surname>Zheng</surname><given-names>Y. T.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Phylodynamics of HIV-1 unique recombinant forms in China-Myanmar border: implication for HIV-1 transmission to Myanmar from Dehong, China.</article-title>
<source><italic>Infect. Genet. Evol.</italic></source>
<volume>12</volume>
<fpage>1944</fpage>&#x02013;<lpage>1948</lpage>. <pub-id pub-id-type="doi">10.1016/j.meegid.2012.08.001</pub-id>
<?supplied-pmid 22917657?><pub-id pub-id-type="pmid">22917657</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Yuan</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>T.</given-names></name><name><surname>Okamoto</surname><given-names>H.</given-names></name><name><surname>Murphy</surname><given-names>D. G.</given-names></name></person-group> (<year>2013</year>). <article-title>Full-length genome sequences of five Hepatitis C virus isolates representing subtypes 3g, 3h, 3i and 3k, and a unique genotype 3 variant.</article-title>
<source><italic>J. Gen. Virol.</italic></source>
<volume>94</volume>
<fpage>543</fpage>&#x02013;<lpage>548</lpage>. <pub-id pub-id-type="doi">10.1099/vir.0.049668-0</pub-id>
<?supplied-pmid 23152370?><pub-id pub-id-type="pmid">23152370</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>L.</given-names></name><name><surname>Nakano</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Miller</surname><given-names>S.</given-names></name><name><surname>Kuiken</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Hepatitis C virus complete genome sequences identified from China representing subtypes 6k and 6n and a novel, as yet unassigned subtype within genotype 6.</article-title>
<source><italic>J. Gen. Virol.</italic></source>
<volume>87</volume>
<fpage>629</fpage>&#x02013;<lpage>634</lpage>. <pub-id pub-id-type="doi">10.1099/vir.0.81400-0</pub-id>
<?supplied-pmid 16476984?><pub-id pub-id-type="pmid">16476984</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luhmann</surname><given-names>N.</given-names></name><name><surname>Champagnat</surname><given-names>J.</given-names></name><name><surname>Golovin</surname><given-names>S.</given-names></name><name><surname>Maistat</surname><given-names>L.</given-names></name><name><surname>Agustian</surname><given-names>E.</given-names></name><name><surname>Inaridze</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Access to Hepatitis C treatment for people who inject drugs in low and middle income settings: evidence from 5 countries in Eastern Europe and Asia.</article-title>
<source><italic>Int. J. Drug Policy</italic></source>
<volume>26</volume>
<fpage>1081</fpage>&#x02013;<lpage>1087</lpage>. <pub-id pub-id-type="doi">10.1016/j.drugpo.2015.07.016</pub-id>
<?supplied-pmid 26342273?><pub-id pub-id-type="pmid">26342273</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lwin</surname><given-names>A. A.</given-names></name><name><surname>Aye</surname><given-names>K. S.</given-names></name><name><surname>Htun</surname><given-names>M. H.</given-names></name><name><surname>Kyaw</surname><given-names>Y. Y.</given-names></name><name><surname>Zaw</surname><given-names>K. K.</given-names></name><name><surname>Aung</surname><given-names>T. T.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Sero-prevalence of Hepatitis B and C Viral Infections in Myanmar: national and regional survey in 2015.</article-title>
<source><italic>Myanmar Health Sci. Res. J.</italic></source>
<volume>29</volume>
<fpage>167</fpage>&#x02013;<lpage>175</lpage>.</mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lwin</surname><given-names>A. A.</given-names></name><name><surname>Shinji</surname><given-names>T.</given-names></name><name><surname>Khin</surname><given-names>M.</given-names></name><name><surname>Win</surname><given-names>N.</given-names></name><name><surname>Obika</surname><given-names>M.</given-names></name><name><surname>Okada</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Hepatitis C virus genotype distribution in Myanmar: predominance of genotype 6 and existence of new genotype 6 subtype.</article-title>
<source><italic>Hepatol. Res.</italic></source>
<volume>37</volume>
<fpage>337</fpage>&#x02013;<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1111/j.1872-034X.2007.00053.x</pub-id>
<?supplied-pmid 17441806?><pub-id pub-id-type="pmid">17441806</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martell</surname><given-names>M.</given-names></name><name><surname>Esteban</surname><given-names>J. I.</given-names></name><name><surname>Quer</surname><given-names>J.</given-names></name><name><surname>Genesca</surname><given-names>J.</given-names></name><name><surname>Weiner</surname><given-names>A.</given-names></name><name><surname>Esteban</surname><given-names>R.</given-names></name><etal/></person-group> (<year>1992</year>). <article-title>Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution.</article-title>
<source><italic>J. Virol.</italic></source>
<volume>66</volume>
<fpage>3225</fpage>&#x02013;<lpage>3229</lpage>.<pub-id pub-id-type="pmid">1313927</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messina</surname><given-names>J. P.</given-names></name><name><surname>Humphreys</surname><given-names>I.</given-names></name><name><surname>Flaxman</surname><given-names>A.</given-names></name><name><surname>Brown</surname><given-names>A.</given-names></name><name><surname>Cooke</surname><given-names>G. S.</given-names></name><name><surname>Pybus</surname><given-names>O. G.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Global distribution and prevalence of hepatitis C virus genotypes.</article-title>
<source><italic>Hepatology</italic></source>
<volume>61</volume>
<fpage>77</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1002/hep.27259</pub-id>
<?supplied-pmid 25069599?><pub-id pub-id-type="pmid">25069599</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><collab>Ministry of Health and Sports Myanmar</collab> (<year>2017</year>). <source><italic>Simplified Treatment Guidelines for Hepatitis C Infection</italic></source>. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.aidsdatahub.org/simplified-treatment-guidelines-hepatitis-c-infection-ministry-health-and-sports-myanmar-2017">https://www.aidsdatahub.org/simplified-treatment-guidelines-hepatitis-c-infection-ministry-health-and-sports-myanmar-2017</ext-link> (accessed April 9, 2019).</mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pei</surname><given-names>D.</given-names></name><name><surname>Weiss</surname><given-names>S. J.</given-names></name></person-group> (<year>1995</year>). <article-title>Furin-dependent intracellular activation of the human stromelysin-3 zymogen.</article-title>
<source><italic>Nature</italic></source>
<volume>375</volume>
<fpage>244</fpage>&#x02013;<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1038/375244a0</pub-id>
<?supplied-pmid 7746327?><pub-id pub-id-type="pmid">7746327</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Hao</surname><given-names>F.</given-names></name><name><surname>Wan</surname><given-names>Z.</given-names></name><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Lu</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Subtype distribution of hepatitis C virus in Jiangsu, China.</article-title>
<source><italic>J. Med. Virol.</italic></source>
<volume>88</volume>
<fpage>498</fpage>&#x02013;<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.24356</pub-id>
<?supplied-pmid 26288243?><pub-id pub-id-type="pmid">26288243</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinji</surname><given-names>T.</given-names></name><name><surname>Kyaw</surname><given-names>Y. Y.</given-names></name><name><surname>Gokan</surname><given-names>K.</given-names></name><name><surname>Tanaka</surname><given-names>Y.</given-names></name><name><surname>Ochi</surname><given-names>K.</given-names></name><name><surname>Kusano</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Analysis of HCV genotypes from blood donors shows three new HCV type 6 subgroups exist in Myanmar.</article-title>
<source><italic>Acta Med. Okayama</italic></source>
<volume>58</volume>
<fpage>135</fpage>&#x02013;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.18926/amo/32110</pub-id>
<?supplied-pmid 15471435?><pub-id pub-id-type="pmid">15471435</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>D. B.</given-names></name><name><surname>Bukh</surname><given-names>J.</given-names></name><name><surname>Kuiken</surname><given-names>C.</given-names></name><name><surname>Muerhoff</surname><given-names>A. S.</given-names></name><name><surname>Rice</surname><given-names>C. M.</given-names></name><name><surname>Stapleton</surname><given-names>J. T.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Expanded classification of Hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource.</article-title>
<source><italic>Hepatology</italic></source>
<volume>59</volume>
<fpage>318</fpage>&#x02013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1002/hep.26744</pub-id>
<?supplied-pmid 24115039?><pub-id pub-id-type="pmid">24115039</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tellinghuisen</surname><given-names>T. L.</given-names></name><name><surname>Marcotrigiano</surname><given-names>J.</given-names></name><name><surname>Rice</surname><given-names>C. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Structure of the zinc-binding domain of an essential component of the Hepatitis C virus replicase.</article-title>
<source><italic>Nature</italic></source>
<volume>435</volume>
<fpage>374</fpage>&#x02013;<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1038/nature03580</pub-id>
<?supplied-pmid 15902263?><pub-id pub-id-type="pmid">15902263</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thong</surname><given-names>V. D.</given-names></name><name><surname>Akkarathamrongsin</surname><given-names>S.</given-names></name><name><surname>Poovorawan</surname><given-names>K.</given-names></name><name><surname>Tangkijvanich</surname><given-names>P.</given-names></name><name><surname>Poovorawan</surname><given-names>Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication.</article-title>
<source><italic>World J. Gastroenterol.</italic></source>
<volume>20</volume>
<fpage>2927</fpage>&#x02013;<lpage>2940</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v20.i11.2927</pub-id>
<?supplied-pmid 24659883?><pub-id pub-id-type="pmid">24659883</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thong</surname><given-names>V. D.</given-names></name><name><surname>Poovorawan</surname><given-names>K.</given-names></name><name><surname>Tangkijvanich</surname><given-names>P.</given-names></name><name><surname>Wasitthankasem</surname><given-names>R.</given-names></name><name><surname>Vongpunsawad</surname><given-names>S.</given-names></name><name><surname>Poovorawan</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Influence of host and viral factors on patients with chronic Hepatitis C virus genotype 6 treated with pegylated interferon and ribavirin: a systematic review and meta-analysis.</article-title>
<source><italic>Intervirology</italic></source>
<volume>58</volume>
<fpage>373</fpage>&#x02013;<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1159/000444366</pub-id>
<?supplied-pmid 27010195?><pub-id pub-id-type="pmid">27010195</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thu</surname><given-names>A.</given-names></name><name><surname>Thaw</surname><given-names>A.</given-names></name><name><surname>Oo</surname><given-names>K. M.</given-names></name><name><surname>Lwin</surname><given-names>A. A.</given-names></name><name><surname>Lwin</surname><given-names>O.</given-names></name><name><surname>Myint</surname><given-names>A. Z.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Prevalence and associated risks of hepatitis B and C infections among injecting drug users (IDU) attending the registered drug treatment centers in Yangon, Mandalay, Myitkyina, Bamaw and Moekaung in 2007.</article-title>
<source><italic>Myanmar Health Sci. Res. J.</italic></source>
<volume>20</volume>
<fpage>159</fpage>&#x02013;<lpage>164</lpage>.</mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Duo</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Zheng</surname><given-names>Y. T.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>HCV Diversity among Chinese and Burmese IDUs in Dehong, Yunnan, China.</article-title>
<source><italic>PLoS One</italic></source>
<volume>11</volume>:<issue>e0163062</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0163062</pub-id>
<?supplied-pmid 27657722?><pub-id pub-id-type="pmid">27657722</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Yuan</surname><given-names>Z.</given-names></name><name><surname>Barnes</surname><given-names>E.</given-names></name><name><surname>Yuan</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Eight novel Hepatitis C virus genomes reveal the changing taxonomic structure of genotype 6.</article-title>
<source><italic>J. Gen. Virol.</italic></source>
<volume>94</volume>
<fpage>76</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1099/vir.0.047506-0</pub-id>
<?supplied-pmid 23015745?><pub-id pub-id-type="pmid">23015745</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wasitthankasem</surname><given-names>R.</given-names></name><name><surname>Vongpunsawad</surname><given-names>S.</given-names></name><name><surname>Siripon</surname><given-names>N.</given-names></name><name><surname>Suya</surname><given-names>C.</given-names></name><name><surname>Chulothok</surname><given-names>P.</given-names></name><name><surname>Chaiear</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Genotypic distribution of Hepatitis C virus in Thailand and Southeast Asia.</article-title>
<source><italic>PLoS One</italic></source>
<volume>10</volume>:<issue>e0126764</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0126764</pub-id>
<?supplied-pmid 25962112?><pub-id pub-id-type="pmid">25962112</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webster</surname><given-names>D. P.</given-names></name><name><surname>Klenerman</surname><given-names>P.</given-names></name><name><surname>Dusheiko</surname><given-names>G. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Hepatitis C.</article-title>
<source><italic>Lancet</italic></source>
<volume>385</volume>
<fpage>1124</fpage>&#x02013;<lpage>1135</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(14)62401-6</pub-id><pub-id pub-id-type="pmid">25687730</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>L.</given-names></name><name><surname>Hou</surname><given-names>J. L.</given-names></name></person-group> (<year>2015</year>). <article-title>The guideline of prevention and treatment for hepatitis C: a 2015 update.</article-title>
<source><italic>Zhonghua Gan Zang Bing Za Zhi</italic></source>
<volume>23</volume>
<fpage>906</fpage>&#x02013;<lpage>923</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.1007-3418.2015.12.003</pub-id>
<?supplied-pmid 26739465?><pub-id pub-id-type="pmid">26739465</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><collab>WHO</collab> (<year>2017</year>). <source><italic>Global Hepatitis Report 2017.</italic></source> Available at: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/">https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/</ext-link> (accessed April 9, 2019).</mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Win</surname><given-names>N. N.</given-names></name><name><surname>Kanda</surname><given-names>T.</given-names></name><name><surname>Nakamoto</surname><given-names>S.</given-names></name><name><surname>Yokosuka</surname><given-names>O.</given-names></name><name><surname>Shirasawa</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>Hepatitis C virus genotypes in Myanmar.</article-title>
<source><italic>World J. Gastroenterol.</italic></source>
<volume>22</volume>
<fpage>6095</fpage>&#x02013;<lpage>6099</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v22.i27.6095</pub-id>
<?supplied-pmid 27468202?><pub-id pub-id-type="pmid">27468202</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>R. J.</given-names></name><name><surname>Nguyen</surname><given-names>M. T.</given-names></name><name><surname>Trinh</surname><given-names>H. N.</given-names></name><name><surname>Huynh</surname><given-names>A.</given-names></name><name><surname>Ly</surname><given-names>M. T.</given-names></name><name><surname>Nguyen</surname><given-names>H. A.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Community-based real-world treatment outcomes of sofosbuvir/ledipasvir in Asians with chronic hepatitis C virus genotype 6 in the United States.</article-title>
<source><italic>J. Viral Hepat.</italic></source>
<volume>24</volume>
<fpage>17</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1111/jvh.12609</pub-id>
<?supplied-pmid 27677786?><pub-id pub-id-type="pmid">27677786</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>D. B.</given-names></name><name><surname>Jiang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>Y. H.</given-names></name><name><surname>Chen</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>M. L.</given-names></name><name><surname>Tao</surname><given-names>Y. C.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for Hepatitis C virus genotype 6 in Southwest China: real-world experience of a retrospective study.</article-title>
<source><italic>J. Viral Hepat.</italic></source>
<volume>26</volume>
<fpage>316</fpage>&#x02013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1111/jvh.13033</pub-id>
<?supplied-pmid 30380166?><pub-id pub-id-type="pmid">30380166</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T.</given-names></name><name><surname>Xing</surname><given-names>Z.</given-names></name><name><surname>Yuan</surname><given-names>M.</given-names></name><name><surname>Ge</surname><given-names>J.</given-names></name><name><surname>Yuan</surname><given-names>G.</given-names></name><name><surname>Liang</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Analysis of HCV isolates among the Li Ethnic in Hainan Island of South China reveals their HCV-6 unique evolution and a new subtype.</article-title>
<source><italic>Cell. Physiol. Biochem.</italic></source>
<volume>50</volume>
<fpage>1832</fpage>&#x02013;<lpage>1839</lpage>. <pub-id pub-id-type="doi">10.1159/000494863</pub-id>
<?supplied-pmid 30396187?><pub-id pub-id-type="pmid">30396187</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>X.</given-names></name><name><surname>Lu</surname><given-names>L.</given-names></name><name><surname>Tee</surname><given-names>K. K.</given-names></name><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China.</article-title>
<source><italic>J. Med. Virol.</italic></source>
<volume>80</volume>
<fpage>1142</fpage>&#x02013;<lpage>1152</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.21204</pub-id>
<?supplied-pmid 18461611?><pub-id pub-id-type="pmid">18461611</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zein</surname><given-names>N. N.</given-names></name></person-group> (<year>2000</year>). <article-title>Clinical significance of hepatitis C virus genotypes.</article-title>
<source><italic>Clin. Microbiol. Rev.</italic></source>
<volume>13</volume>
<fpage>223</fpage>&#x02013;<lpage>235</lpage>.<pub-id pub-id-type="pmid">10755999</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Wu</surname><given-names>N.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Ge</surname><given-names>Q.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Ren</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>HCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in China.</article-title>
<source><italic>PLoS One</italic></source>
<volume>6</volume>:<issue>e16817</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0016817</pub-id>
<?supplied-pmid 21304823?><pub-id pub-id-type="pmid">21304823</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>R.</given-names></name><name><surname>Xia</surname><given-names>X.</given-names></name><name><surname>Qin</surname><given-names>S.</given-names></name><name><surname>Dai</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China.</article-title>
<source><italic>J. Acquir. Immune Defic. Syndr.</italic></source>
<volume>29</volume>
<fpage>191</fpage>&#x02013;<lpage>196</lpage>. <?supplied-pmid 11832691?><pub-id pub-id-type="pmid">11832691</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Yao</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Feng</surname><given-names>R.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Cun</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Hepatitis C virus genotype diversity among intravenous drug users in Yunnan Province, Southwestern China.</article-title>
<source><italic>PLoS One</italic></source>
<volume>8</volume>:<issue>e82598</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0082598</pub-id>
<?supplied-pmid 24358211?><pub-id pub-id-type="pmid">24358211</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y. H.</given-names></name><name><surname>Liu</surname><given-names>F. L.</given-names></name><name><surname>Yao</surname><given-names>Z. H.</given-names></name><name><surname>Duo</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border region.</article-title>
<source><italic>PLoS One</italic></source>
<volume>6</volume>:<issue>e16349</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0016349</pub-id>
<?supplied-pmid 21283696?><pub-id pub-id-type="pmid">21283696</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y. H.</given-names></name><name><surname>Yao</surname><given-names>Z. H.</given-names></name><name><surname>Liu</surname><given-names>F. L.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Jiang</surname><given-names>L.</given-names></name><name><surname>Zhu</surname><given-names>J. W.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>High prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan province, China.</article-title>
<source><italic>PLoS One</italic></source>
<volume>7</volume>:<issue>e42937</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0042937</pub-id>
<?supplied-pmid 22916185?><pub-id pub-id-type="pmid">22916185</pub-id></mixed-citation></ref></ref-list></back></article>